Related Experiment Video
Updated: Oct 1, 2026

Use of the EpiAirway Model for Characterizing Long-term Host-pathogen Interactions
Published on: September 2, 2011
Neisseria models of infection and persistence in the upper respiratory tract
Abstract:
The Gram-negative bacteria genus Neisseria includes both pathogenic and commensal species that are found primarily in the upper respiratory tract of humans and animals. The development of animal models to study neisserial pathogenesis has focused almost exclusively on two species that cause disease in humans. These include Neisseria meningitidis, an obligate commensal that can cause invasive disease, and N. gonorrhoeae, the causative agent of gonorrhea. Both pathogens can persist in the upper respiratory tract. This article will give a brief overview of the genus Neisseria. The anatomy of the upper respiratory tract and its use as a niche for bacteria will be discussed. Next, studies that provide insight about the first stage of upper respiratory tract infection, namely colonization, will be reviewed. Most studies of upper respiratory tract infection have focused on N. meningitidis infections of laboratory mice. This review will also discuss models of respiratory tract persistence by Neisseria species, including commensals, in mice, non-human primates and human volunteers. The article includes a section that discusses the future utility of upper respiratory tract models in informing the development of effective antimicrobial therapies. Such knowledge is needed to minimize the dissemination of antimicrobial resistance from respiratory reservoirs.
Insights
This review explores Neisseria bacteria in the upper respiratory tract, focusing on colonization and persistence models. Understanding these models is crucial for developing new antimicrobial therapies and combating resistance.
Area of Science:
- Microbiology
- Immunology
- Infectious Diseases
Background:
- The genus Neisseria comprises pathogenic and commensal Gram-negative bacteria residing in the human and animal upper respiratory tract.
- Neisseria meningitidis and Neisseria gonorrhoeae are key human pathogens studied for their ability to cause invasive disease and persist in the respiratory tract.
Purpose of the Study:
- To provide an overview of the genus Neisseria.
- To discuss the upper respiratory tract as a bacterial niche.
- To review studies on Neisseria colonization and persistence, including animal and human models.
Main Methods:
- Review of existing literature on Neisseria species.
- Discussion of anatomical features of the upper respiratory tract as a bacterial niche.
- Analysis of various animal models (mice, non-human primates) and human volunteer studies for Neisseria persistence.
Main Results:
- Neisseria species, both pathogenic and commensal, colonize and persist in the upper respiratory tract.
- Animal models, particularly in mice, have been instrumental in studying Neisseria meningitidis infections.
- Diverse models exist to study respiratory tract persistence, offering insights into bacterial-host interactions.
Conclusions:
- Understanding Neisseria colonization and persistence in the upper respiratory tract is vital.
- Developing effective upper respiratory tract models is essential for advancing antimicrobial therapies.
- Minimizing antimicrobial resistance spread from respiratory reservoirs requires further research into these models.
More Related Videos
09:12Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae
Published on: January 17, 2014
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
Related Concept Videos
Anatomy of Respiratory System I: Upper Respiratory Tract
Nose and nasal cavity
The nose and nasal cavity represent the main external openings of the respiratory tract.
Microbiota of the Respiratory Tract
Colonisation of Pathogens
Atypical Pneumonia
Respiratory Syncytial Virus Disease
Bacterial Meningitis II: Pathophysiology